Detalles de la búsqueda
1.
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.
Biol Blood Marrow Transplant
; 26(4): 665-671, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881283
2.
Characteristics and Outcomes of Stem Cell Transplant Patients during the COVID-19 Era: A Systematic Review and Meta-Analysis.
Healthcare (Basel)
; 12(5)2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38470640
3.
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning.
Transplant Cell Ther
; 29(12): 770.e1-770.e6, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37742746
4.
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
Blood Adv
; 7(22): 7007-7016, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37792849
5.
CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges.
Blood Lymphat Cancer
; 12: 119-136, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36060553
6.
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.
Blood Adv
; 6(7): 2267-2274, 2022 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008100
7.
Patient-Reported Outcomes for Cancer Patients with Hematological Malignancies Undergoing Chimeric Antigen Receptor T Cell Therapy: A Systematic Review.
Transplant Cell Ther
; 27(5): 390.e1-390.e7, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33965176
8.
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid Leukemia.
Transplant Cell Ther
; 27(8): 689-695, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023569
9.
Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Transplant Cell Ther
; 27(5): 404.e1-404.e5, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33965178
10.
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation.
J Immunother Cancer
; 9(2)2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33637601
11.
A Mildly Symptomatic Middle-Aged Woman with INT-1 Primary Myelofibrosis.
Clin Lymphoma Myeloma Leuk
; 20 Suppl 1: S19, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32862853
12.
Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation.
JTO Clin Res Rep
; 1(3): 100049, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589945
13.
When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease.
Semin Hematol
; 55(2): 94-101, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29958565
14.
Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue.
J Investig Med High Impact Case Rep
; 6: 2324709618786769, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30083561
15.
Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
Semin Hematol
; 55(2): 87-93, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29958564
16.
Improving Survival After Transplant in Myelofibrosis.
Clin Lymphoma Myeloma Leuk
; 20 Suppl 1: S72-S73, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32862877
Resultados
1 -
16
de 16
1
Próxima >
>>